GEHC - GE HealthCare Technologies Inc.
NASDAQ
->
Healthcare
->
Health Information Services
Chicago,
United States
Type: Equity
GEHC price evolution
GEHC
| (in millions $) | 30 Oct 2024 | 30 Jul 2024 | 1 May 2024 | 31 Jan 2024 |
|---|---|---|---|---|
| Current assets | ||||
| Cash | ||||
| Short term investments | ||||
| Net receivables | $4470 | $4331 | $4305 | $4557 |
| Inventory | $2124 | $2023 | $1989 | $1960 |
| Total current assets | $10638 | $8806 | $9373 | $9410 |
| Long term investments | ||||
| Property, plant & equipment | $2539 | $2458 | $2445 | $2500 |
| Goodwill & intangible assets | ||||
| Total noncurrent assets | ||||
| Total investments | ||||
| Total assets | $33855 | $31852 | $32208 | $32454 |
| Current liabilities | ||||
| Accounts payable | $2911 | $2824 | $2931 | $2947 |
| Deferred revenue | ||||
| Short long term debt | ||||
| Total current liabilities | $8670 | $8318 | $8859 | $8981 |
| Long term debt | $9306 | $8233 | $8247 | $8436 |
| Total noncurrent liabilities | ||||
| Total debt | ||||
| Total liabilities | $25538 | $24051 | $24799 | $25321 |
| Shareholders' equity | ||||
| Retained earnings | $2558 | $2101 | $1687 | $1326 |
| Other shareholder equity | -$772 | -$845 | -$787 | -$691 |
| Total shareholder equity | ||||
| (in millions $) | 31 Jan 2024 | 31 Jan 2023 | 31 Jan 2022 | 31 Jan 2021 |
|---|---|---|---|---|
| Current assets | ||||
| Cash | ||||
| Short term investments | ||||
| Net receivables | $4557 | $4301 | $4061 | $2882 |
| Inventory | $1960 | $2155 | $1946 | $1594 |
| Total current assets | $9410 | $8318 | $7000 | $5896 |
| Long term investments | ||||
| Property, plant & equipment | $2500 | $2314 | $2235 | $2202 |
| Goodwill & intangible assets | ||||
| Total noncurrent assets | ||||
| Total investments | ||||
| Total assets | $32454 | $27539 | $26308 | $24228 |
| Current liabilities | ||||
| Accounts payable | $2947 | $2944 | $2540 | $2162 |
| Deferred revenue | ||||
| Short long term debt | ||||
| Total current liabilities | $8981 | $7191 | $6761 | $6524 |
| Long term debt | $8436 | $8234 | $31 | $31 |
| Total noncurrent liabilities | ||||
| Total debt | ||||
| Total liabilities | $25321 | $18182 | $9653 | $9501 |
| Shareholders' equity | ||||
| Retained earnings | $1326 | $11235 | $17692 | $15566 |
| Other shareholder equity | -$691 | -$1878 | -$1037 | -$839 |
| Total shareholder equity | ||||
| (in millions $) | 30 Oct 2024 | 30 Jul 2024 | 1 May 2024 | 31 Jan 2024 |
|---|---|---|---|---|
| Revenue | ||||
| Total revenue | $4863 | $4839 | $4650 | $5206 |
| Cost of revenue | ||||
| Gross Profit | $2025 | $2002 | $1901 | $2156 |
| Operating activities | ||||
| Research & development | ||||
| Selling, general & administrative | ||||
| Total operating expenses | $1349 | $1394 | $1361 | $1467 |
| Operating income | ||||
| Income from continuing operations | ||||
| EBIT | ||||
| Income tax expense | $168 | $143 | $124 | $193 |
| Interest expense | -$123 | -$129 | -$137 | -$122 |
| Net income | ||||
| Net income | $470 | $428 | $374 | $403 |
| Income (for common shares) | ||||
| (in millions $) | 31 Jan 2024 | 31 Jan 2023 | 31 Jan 2022 | 31 Jan 2021 |
|---|---|---|---|---|
| Revenue | ||||
| Total revenue | $19552 | $18341 | $17585 | $17164 |
| Cost of revenue | ||||
| Gross Profit | $7922 | $7179 | $7174 | $6767 |
| Operating activities | ||||
| Research & development | ||||
| Selling, general & administrative | ||||
| Total operating expenses | $5487 | $4657 | $4379 | $4047 |
| Operating income | ||||
| Income from continuing operations | ||||
| EBIT | ||||
| Income tax expense | $743 | $563 | $600 | $652 |
| Interest expense | -$505 | -$81 | -$101 | -$122 |
| Net income | ||||
| Net income | $1385 | $1916 | $2247 | $13846 |
| Income (for common shares) | ||||
| (in millions $) | 30 Oct 2024 | 30 Jul 2024 | 1 May 2024 | 31 Jan 2024 |
|---|---|---|---|---|
| Net income | ||||
| Operating activities | ||||
| Depreciation | ||||
| Business acquisitions & disposals | ||||
| Stock-based compensation | ||||
| Total cash flows from operations | ||||
| Investing activities | ||||
| Capital expenditures | ||||
| Investments | ||||
| Total cash flows from investing | -$674 | -$537 | -$188 | -$558 |
| Financing activities | ||||
| Dividends paid | -$41 | -$28 | -$14 | -$41 |
| Sale and purchase of stock | ||||
| Net borrowings | ||||
| Total cash flows from financing | $704 | -$210 | -$153 | -$478 |
| Effect of exchange rate | -$2 | -$41 | -$19 | -$10 |
| Change in cash and equivalents | $1066 | -$488 | $59 | $1055 |
| (in millions $) | 31 Jan 2024 | 31 Jan 2023 | 31 Jan 2022 | 31 Jan 2021 |
|---|---|---|---|---|
| Net income | ||||
| Operating activities | ||||
| Depreciation | ||||
| Business acquisitions & disposals | ||||
| Stock-based compensation | ||||
| Total cash flows from operations | ||||
| Investing activities | ||||
| Capital expenditures | ||||
| Investments | ||||
| Total cash flows from investing | -$558 | -$398 | -$1761 | -$323 |
| Financing activities | ||||
| Dividends paid | -$41 | |||
| Sale and purchase of stock | ||||
| Net borrowings | ||||
| Total cash flows from financing | -$478 | -$822 | -$263 | -$2166 |
| Effect of exchange rate | -$10 | -$3 | -$34 | $14 |
| Change in cash and equivalents | $1055 | $890 | -$451 | $143 |
News
Fundamentals
| Market cap | $35.30B |
|---|---|
| Enterprise value | N/A |
| Shares outstanding | 456.85M |
| Revenue | $19.56B |
|---|---|
| EBITDA | N/A |
| EBIT | N/A |
| Net Income | $1.68B |
| Revenue Q/Q | N/A |
| Revenue Y/Y | N/A |
| P/E ratio | 21.07 |
|---|---|
| EV/Sales | N/A |
| EV/EBITDA | N/A |
| EV/EBIT | N/A |
| P/S ratio | 1.80 |
| P/B ratio | N/A |
| Book/Share | N/A |
| Cash/Share | N/A |
| EPS | $3.67 |
|---|---|
| ROA | 5.14% |
| ROE | N/A |
| Debt/Equity | N/A |
|---|---|
| Net debt/EBITDA | N/A |
| Current ratio | 1.23 |
| Quick ratio | 0.98 |